Cancer Research Cancer Epigenetics  Jordan
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

[Cancer Research 33, 1146-1149, June 1, 1973]
© 1973 American Association for Cancer Research

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Medoff, G.
Right arrow Articles by Kobayashi, G. S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Medoff, G.
Right arrow Articles by Kobayashi, G. S.

Potentiation of Rifampicin, Rifampicin Analogs, and Tetracycline against Animal Cells by Amphotericin B and Polymyxin B1

G. Medoff, C. N. Kwan, D. Schlessinger and G. S. Kobayashi

Divisions of Infectious Diseases [G. M.] and Dermatology [G. S. K.], Department of Medicine, and Department of Microbiology, Washington University School of Medicine, St. Louis, Missouri 63110

The membrane-active antibiotics amphotericin B and polymyxin B enhanced the action of rifampicin, rifampicin analogs, and tetracycline against macromolecular synthesis and growth of mouse L-cells, human HeLa cells, and KB cells in tissue culture. The specificities of the second agents were maintained in that rifampicin inhibited RNA synthesis and tetracycline inhibited protein synthesis.

1 Supported by USPHS Research Grants 1 RO1 AI 10622, AI 06213, and CA-125602-1 and by Training Grant AM 05611 and a grant from the John A. Hartford Foundation, Inc.

Received 12/18/72. Accepted 2/19/73.




This article has been cited by other articles:


Home page
JAMAHome page
G. Medoff and G. S. Kobayashi
Amphotericin B: Old Drug, New Therapy
JAMA, May 12, 1975; 232(6): 619 - 620.
[Abstract] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 1973 by the American Association for Cancer Research.